Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Net Income towards Common Stockholders (2016 - 2025)

Pediatrix Medical (MD) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with $45.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 61.03% to $45.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $177.3 million, a 275.14% increase, with the full-year FY2025 number at $216.4 million, changed N/A from a year prior.
  • Net Income towards Common Stockholders was $45.6 million for Q4 2025 at Pediatrix Medical, down from $71.7 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $71.7 million in Q3 2025 to a low of -$153.0 million in Q2 2024.
  • A 4-year average of $6.4 million and a median of $6.4 million in 2021 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: skyrocketed 5869.95% in 2021, then tumbled 179.61% in 2022.
  • Pediatrix Medical's Net Income towards Common Stockholders stood at $7.2 million in 2021, then decreased by 21.77% to $5.7 million in 2022, then soared by 400.34% to $28.3 million in 2024, then surged by 61.03% to $45.6 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Net Income towards Common Stockholders are $45.6 million (Q4 2025), $71.7 million (Q3 2025), and $39.3 million (Q2 2025).